首页 > 最新文献

Family practice最新文献

英文 中文
Change of pulmonary function tests in hospitalized COVID-19 patients at third and sixth month follow-up. COVID-19 住院患者在第三个月和第六个月随访时肺功能测试的变化。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmac145
Meltem Karakulak Kafkas, Sabah Tüzün, Nazlı Hacıağaoğlu, Hüseyin Çetin, Sevda Şener Cömert, Engin Ersin Şimşek

Background: The effect of COVID-19 infection on pulmonary function is unknown.

Objective: This study aimed to evaluate pulmonary function tests (PFTs) of patients hospitalized with the diagnosis of COVID-19 pneumonia at 3 and 6 months post-discharge.

Methods: Patients aged 18 years and over who had positive COVID-19 PCR test results and were hospitalized in the pandemic service between 1 May 2020 and 31 October 2020, were included in the study. All patients were evaluated with PFTs FVC, FEV1, FEV1/FVC, and FEF25-75 at 3 and 6 months after discharge.

Results: The mean age of 34 patients included in the study was 47.7 ± 12.7 years. The FVC, FEV1, FEV1/FVC, and FEF25-75 measurements at 3 and 6 months post-discharge showed no significant difference (P = 0.765, P = 0.907, P = 0.707, and P = 0.674, respectively). There was no significant difference in any PFT measurements at the third month follow-up, regardless of the pharmacological treatment protocols applied during hospitalization (P > 0.05). However, FEV1/FVC and FEF25-75 levels were 83.1 [3.4]% and 91.0 [10.0]%, respectively, in those who received systemic steroid treatment, and 78.3 ± 8.5% and 72.5 ± 25.7% in those who did not (P = 0.019 and P = 0.048, respectively). In addition, FVC and FEV1 levels increased significantly from the third to the sixth month follow-up in patients who received systemic steroid therapy (P = 0.035 and P = 0.018, respectively).

Conclusion: Although there is no significant difference in PFT measurements from 3 to 6 months in COVID-19 patients, systemic steroid therapy may have a beneficial effect on respiratory function in COVID-19 patients.

背景:COVID-19感染对肺功能的影响尚不清楚:COVID-19感染对肺功能的影响尚不清楚:本研究旨在评估确诊为COVID-19肺炎的住院患者在出院后3个月和6个月时的肺功能测试(PFT):研究纳入了在 2020 年 5 月 1 日至 2020 年 10 月 31 日期间在大流行病服务机构住院且 COVID-19 PCR 检测结果呈阳性的 18 岁及以上患者。所有患者均在出院后3个月和6个月接受了PFT FVC、FEV1、FEV1/FVC和FEF25-75评估:34名患者的平均年龄为(47.7 ± 12.7)岁。出院后 3 个月和 6 个月的 FVC、FEV1、FEV1/FVC 和 FEF25-75 测量结果无显著差异(分别为 P = 0.765、P = 0.907、P = 0.707 和 P = 0.674)。在第三个月的随访中,无论住院期间采用何种药物治疗方案,PFT 测量结果均无明显差异(P > 0.05)。然而,接受全身类固醇治疗的患者的 FEV1/FVC 和 FEF25-75 分别为 83.1 [3.4]% 和 91.0 [10.0]%,而未接受全身类固醇治疗的患者分别为 78.3 ± 8.5% 和 72.5 ± 25.7%(P = 0.019 和 P = 0.048)。此外,接受全身类固醇治疗的患者的 FVC 和 FEV1 水平在随访的第三个月至第六个月期间显著增加(分别为 P = 0.035 和 P = 0.018):结论:虽然 COVID-19 患者 3 至 6 个月的 PFT 测量结果无明显差异,但全身性类固醇治疗可能对 COVID-19 患者的呼吸功能有益。
{"title":"Change of pulmonary function tests in hospitalized COVID-19 patients at third and sixth month follow-up.","authors":"Meltem Karakulak Kafkas, Sabah Tüzün, Nazlı Hacıağaoğlu, Hüseyin Çetin, Sevda Şener Cömert, Engin Ersin Şimşek","doi":"10.1093/fampra/cmac145","DOIUrl":"10.1093/fampra/cmac145","url":null,"abstract":"<p><strong>Background: </strong>The effect of COVID-19 infection on pulmonary function is unknown.</p><p><strong>Objective: </strong>This study aimed to evaluate pulmonary function tests (PFTs) of patients hospitalized with the diagnosis of COVID-19 pneumonia at 3 and 6 months post-discharge.</p><p><strong>Methods: </strong>Patients aged 18 years and over who had positive COVID-19 PCR test results and were hospitalized in the pandemic service between 1 May 2020 and 31 October 2020, were included in the study. All patients were evaluated with PFTs FVC, FEV1, FEV1/FVC, and FEF25-75 at 3 and 6 months after discharge.</p><p><strong>Results: </strong>The mean age of 34 patients included in the study was 47.7 ± 12.7 years. The FVC, FEV1, FEV1/FVC, and FEF25-75 measurements at 3 and 6 months post-discharge showed no significant difference (P = 0.765, P = 0.907, P = 0.707, and P = 0.674, respectively). There was no significant difference in any PFT measurements at the third month follow-up, regardless of the pharmacological treatment protocols applied during hospitalization (P > 0.05). However, FEV1/FVC and FEF25-75 levels were 83.1 [3.4]% and 91.0 [10.0]%, respectively, in those who received systemic steroid treatment, and 78.3 ± 8.5% and 72.5 ± 25.7% in those who did not (P = 0.019 and P = 0.048, respectively). In addition, FVC and FEV1 levels increased significantly from the third to the sixth month follow-up in patients who received systemic steroid therapy (P = 0.035 and P = 0.018, respectively).</p><p><strong>Conclusion: </strong>Although there is no significant difference in PFT measurements from 3 to 6 months in COVID-19 patients, systemic steroid therapy may have a beneficial effect on respiratory function in COVID-19 patients.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"510-517"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10480263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review documenting reasons whether physicians should provide treatment to their family and friends. 系统性综述记录了医生是否应向其家人和朋友提供治疗的原因。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmac142
Francisca Beigel, Marcel Mertz, Sabine Salloch

Background: Physicians are likely to be asked to provide medical care to relatives or friends. Evidence suggests that most physicians treat loved ones during their active years. However, in the academic literature, critical approaches to the matter are dominating. Ethical guidelines often discourage physicians from treating family members and friends outside of exceptional circumstances.

Objective: This systematic review aims to identify reasons for and against treating family and friends as portrayed in the literature published.

Methods: A search string designed for the database "PubMed," snowball sampling, and hand searching was used to identify possibly eligible publications. Seventy-six publications were screened for all reasons presented in favour of and against physicians treating loved ones. Qualitative content analysis was used for data extraction. Combining a deductive and inductive approach, a coding system was developed.

Results: Many publications analysed represent articles portraying personal experiences; fewer show original research. Reasons against and in favour of treating family and friends were identified. Several publications specify conditions under which the treatment of loved ones may be legitimate. The reasons identified can be assigned to a micro or macro level of human interaction.

Conclusions: This systematic review shows that the discourse of physicians treating loved ones is held predominantly in the context of personal experiences. The majority of authors seem to have a rather pragmatic interest in the topic, and systematic or analytic approaches are rare. While most authors mention various codes of ethics, several publications criticize these or consider them insufficient.

背景:医生很可能被要求为亲属或朋友提供医疗服务。有证据表明,大多数医生都会在亲属活跃期间为其提供治疗。然而,在学术文献中,对这一问题持批判态度的人居多。伦理指南通常不鼓励医生在特殊情况外为亲友提供治疗:本系统综述旨在找出已发表文献中描述的支持和反对治疗家人和朋友的原因:方法:使用为数据库 "PubMed "设计的搜索字符串、滚雪球式抽样和人工搜索来确定可能符合条件的出版物。对 76 篇出版物进行了筛选,以了解所有支持和反对医生治疗亲人的理由。数据提取采用了定性内容分析法。结合演绎法和归纳法,制定了一套编码系统:所分析的许多出版物都是描述个人经历的文章,只有少数是原创性研究。找出了反对和赞成对家人和朋友进行治疗的理由。一些出版物明确指出了在哪些条件下对亲友进行治疗是合法的。所确定的理由可归结为微观或宏观层面的人际互动:本系统综述表明,医生对亲人进行治疗的论述主要以个人经历为背景。大多数作者似乎对这一主题抱有相当务实的兴趣,很少采用系统或分析方法。虽然大多数作者都提到了各种伦理规范,但也有一些出版物对这些规范提出了批评或认为它们不够充分。
{"title":"A systematic review documenting reasons whether physicians should provide treatment to their family and friends.","authors":"Francisca Beigel, Marcel Mertz, Sabine Salloch","doi":"10.1093/fampra/cmac142","DOIUrl":"10.1093/fampra/cmac142","url":null,"abstract":"<p><strong>Background: </strong>Physicians are likely to be asked to provide medical care to relatives or friends. Evidence suggests that most physicians treat loved ones during their active years. However, in the academic literature, critical approaches to the matter are dominating. Ethical guidelines often discourage physicians from treating family members and friends outside of exceptional circumstances.</p><p><strong>Objective: </strong>This systematic review aims to identify reasons for and against treating family and friends as portrayed in the literature published.</p><p><strong>Methods: </strong>A search string designed for the database \"PubMed,\" snowball sampling, and hand searching was used to identify possibly eligible publications. Seventy-six publications were screened for all reasons presented in favour of and against physicians treating loved ones. Qualitative content analysis was used for data extraction. Combining a deductive and inductive approach, a coding system was developed.</p><p><strong>Results: </strong>Many publications analysed represent articles portraying personal experiences; fewer show original research. Reasons against and in favour of treating family and friends were identified. Several publications specify conditions under which the treatment of loved ones may be legitimate. The reasons identified can be assigned to a micro or macro level of human interaction.</p><p><strong>Conclusions: </strong>This systematic review shows that the discourse of physicians treating loved ones is held predominantly in the context of personal experiences. The majority of authors seem to have a rather pragmatic interest in the topic, and systematic or analytic approaches are rare. While most authors mention various codes of ethics, several publications criticize these or consider them insufficient.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"395-403"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10468928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Very rapid decarbonization of primary care: could learning from COVID pandemic help us prepare? 初级医疗的快速去碳化:从 COVID 大流行中汲取的经验能否帮助我们做好准备?
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmac143
James N Smith, Louisa Yapp, Timoleon Kipouros
{"title":"Very rapid decarbonization of primary care: could learning from COVID pandemic help us prepare?","authors":"James N Smith, Louisa Yapp, Timoleon Kipouros","doi":"10.1093/fampra/cmac143","DOIUrl":"10.1093/fampra/cmac143","url":null,"abstract":"","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"623-625"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9091174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public expectations of good primary health care in China: a national qualitative study. 中国公众对良好初级卫生保健的期望:一项全国性定性研究。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmac149
Wenhua Wang, Ruixue Zhao, Jinnan Zhang, Tiange Xu, Jiao Lu, Stephen Nicholas, Xiaolin Wei, Xiaoyun Liu, Huiyun Yang, Elizabeth Matiland

Background: China is currently making efforts to transform the current hospital-centric service delivery system to people-centred primary health care (PHC)-based delivery system, with service delivery organized around the health needs and expectations of people. To help direct China's PHC reform efforts, a profile of high-quality PHC from the public's perspective is required.

Objectives: To profile high-quality PHC from the perspective of the Chinese public.

Methods: Semistructured interviews were conducted in 6 provinces (Henan, Shandong, Zhejiang, Shaanxi, Shanxi, and Heilongjiang) in China. In total, 58 interviewees completed the recorded interview. For transcription, trained research assistant listened to the recording of the interviews, summarizing each 30-s segment in English. Next, thematic analysis was performed on the narrative summaries to identify thematic families.

Results: Seven themes and 16 subthemes were generated from the analysis of our interview data. In order of their frequency, the interviewees expressed a high expectation for interpersonal communication and technical quality; followed by access, comprehensive care, cost, continuity, and coordination.

Conclusions: Using qualitative data from 6 provinces in China, knowledge was generated to reveal the public's views and expectations for high-quality PHC. Our results confirm the urgent need for quality improvement efforts to improve patient experience and technical quality. The government also needs to further improve the delivery system and medical training programme to better meet public expectation in these areas, especially in establishing an innovative integrated primary care model, and strengthening interpersonal and clinical competency training for family doctors.

背景:中国目前正在努力将目前以医院为中心的服务体系转变为以人为本的初级卫生保健(PHC)服务体系,围绕人们的健康需求和期望提供服务。为了帮助指导中国的初级卫生保健改革工作,需要从公众的角度对高质量的初级卫生保健进行剖析:从中国公众的视角出发,对高质量的初级保健服务进行剖析:方法:在中国 6 个省(河南、山东、浙江、陕西、山西和黑龙江)进行了半结构式访谈。共有 58 位受访者完成了访谈录音。在转录过程中,训练有素的研究助理聆听了访谈录音,并用英语总结了每个 30 秒的片段。然后,对叙述性摘要进行主题分析,以确定主题族:对访谈数据的分析产生了 7 个主题和 16 个次主题。按频率排序,受访者对人际沟通和技术质量的期望较高,其次是可及性、综合护理、成本、连续性和协调性:通过使用来自中国 6 个省的定性数据,我们了解了公众对高质量初级保健服务的看法和期望。我们的研究结果证实,迫切需要开展质量改进工作,以改善患者体验和技术质量。政府还需要进一步改善医疗服务体系和医疗培训计划,以更好地满足公众在这些方面的期望,尤其是在建立创新的综合初级保健模式、加强家庭医生的人际关系和临床能力培训方面。
{"title":"Public expectations of good primary health care in China: a national qualitative study.","authors":"Wenhua Wang, Ruixue Zhao, Jinnan Zhang, Tiange Xu, Jiao Lu, Stephen Nicholas, Xiaolin Wei, Xiaoyun Liu, Huiyun Yang, Elizabeth Matiland","doi":"10.1093/fampra/cmac149","DOIUrl":"10.1093/fampra/cmac149","url":null,"abstract":"<p><strong>Background: </strong>China is currently making efforts to transform the current hospital-centric service delivery system to people-centred primary health care (PHC)-based delivery system, with service delivery organized around the health needs and expectations of people. To help direct China's PHC reform efforts, a profile of high-quality PHC from the public's perspective is required.</p><p><strong>Objectives: </strong>To profile high-quality PHC from the perspective of the Chinese public.</p><p><strong>Methods: </strong>Semistructured interviews were conducted in 6 provinces (Henan, Shandong, Zhejiang, Shaanxi, Shanxi, and Heilongjiang) in China. In total, 58 interviewees completed the recorded interview. For transcription, trained research assistant listened to the recording of the interviews, summarizing each 30-s segment in English. Next, thematic analysis was performed on the narrative summaries to identify thematic families.</p><p><strong>Results: </strong>Seven themes and 16 subthemes were generated from the analysis of our interview data. In order of their frequency, the interviewees expressed a high expectation for interpersonal communication and technical quality; followed by access, comprehensive care, cost, continuity, and coordination.</p><p><strong>Conclusions: </strong>Using qualitative data from 6 provinces in China, knowledge was generated to reveal the public's views and expectations for high-quality PHC. Our results confirm the urgent need for quality improvement efforts to improve patient experience and technical quality. The government also needs to further improve the delivery system and medical training programme to better meet public expectation in these areas, especially in establishing an innovative integrated primary care model, and strengthening interpersonal and clinical competency training for family doctors.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"564-570"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10430296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do prescription stimulants increase risk of Parkinson's disease among adults with attention-deficit hyperactivity disorder? A retrospective cohort study. 处方兴奋剂会增加注意力缺陷多动障碍成人罹患帕金森病的风险吗?一项回顾性队列研究。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmac153
Hailey M Kindt, Wen-Jan Tuan, Curtis W Bone

Background: Parkinson's disease (PD) is a common neurodegenerative disorder in older adults that is associated with neuroinflammation, oxidative stress, and characterized by loss of dopaminergic cells. Illicit stimulants increase oxidative stress and are associated with increased risk of PD. Prescription stimulants are similar in mechanism to illicit stimulants, yet their influence on PD is not well described. This study aims to determine if prescription stimulants influence risk of PD among older adults with attention-deficit and hyperactivity disorder (ADHD).

Methods: We implemented a retrospective observational cohort design utilizing the TriNetX database which sources from the electronic health records of 57 healthcare organizations. Inclusion criteria were ADHD diagnosis and age ≥50. Those exposed to stimulants and the unexposed controls were matched based on demographics and known risk factors for PD. The outcome of interest was the incidence of PD over a 30-year follow-up period. We utilized TriNetX software for hazard ratio (HR) analysis.

Results: Among the 59,471 individuals treated with prescription stimulants 131 of them developed PD, and there were 272 individuals who developed PD that were not prescribed stimulants. This analysis yielded a HR of 0.419 (HR = 0.419 [95% CI 0.34, 0.516], P = 0.0013).

Conclusion: Illicit stimulants are associated with increased risk of PD, but this study suggests prescribed stimulants may not impart that same risk. The reduced risk in this cohort may be due to protection from illicit substance use and oxidative stress, however additional study exploring the relationship between prescription stimulants and PD is warranted.

背景:帕金森病(PD)是老年人常见的神经退行性疾病,与神经炎症、氧化应激有关,以多巴胺能细胞的丧失为特征。非法兴奋剂会增加氧化应激,并与帕金森氏症风险增加有关。处方兴奋剂的作用机制与非法兴奋剂相似,但它们对帕金森病的影响尚未得到很好的描述。本研究旨在确定处方兴奋剂是否会影响患有注意力缺陷和多动障碍(ADHD)的老年人罹患帕金森病的风险:我们利用来自 57 家医疗机构电子健康记录的 TriNetX 数据库,采用回顾性观察队列设计。纳入标准为确诊为多动症且年龄≥50岁。暴露于兴奋剂的患者和未暴露于兴奋剂的对照组根据人口统计学特征和已知的帕金森病风险因素进行配对。我们关注的结果是 30 年随访期间的髓鞘脱垂症发病率。我们使用 TriNetX 软件进行了危险比 (HR) 分析:结果:在接受处方兴奋剂治疗的 59471 人中,有 131 人患上了帕金森病,另有 272 人未接受处方兴奋剂治疗但患上了帕金森病。该分析得出的HR值为0.419(HR = 0.419 [95% CI 0.34, 0.516], P = 0.0013):结论:非法兴奋剂与帕金森病风险增加有关,但本研究表明处方兴奋剂可能不会带来同样的风险。该队列中风险降低的原因可能是使用非法药物和氧化应激的保护作用,但还需要进一步研究处方兴奋剂与帕金森病之间的关系。
{"title":"Do prescription stimulants increase risk of Parkinson's disease among adults with attention-deficit hyperactivity disorder? A retrospective cohort study.","authors":"Hailey M Kindt, Wen-Jan Tuan, Curtis W Bone","doi":"10.1093/fampra/cmac153","DOIUrl":"10.1093/fampra/cmac153","url":null,"abstract":"<p><strong>Background: </strong>Parkinson's disease (PD) is a common neurodegenerative disorder in older adults that is associated with neuroinflammation, oxidative stress, and characterized by loss of dopaminergic cells. Illicit stimulants increase oxidative stress and are associated with increased risk of PD. Prescription stimulants are similar in mechanism to illicit stimulants, yet their influence on PD is not well described. This study aims to determine if prescription stimulants influence risk of PD among older adults with attention-deficit and hyperactivity disorder (ADHD).</p><p><strong>Methods: </strong>We implemented a retrospective observational cohort design utilizing the TriNetX database which sources from the electronic health records of 57 healthcare organizations. Inclusion criteria were ADHD diagnosis and age ≥50. Those exposed to stimulants and the unexposed controls were matched based on demographics and known risk factors for PD. The outcome of interest was the incidence of PD over a 30-year follow-up period. We utilized TriNetX software for hazard ratio (HR) analysis.</p><p><strong>Results: </strong>Among the 59,471 individuals treated with prescription stimulants 131 of them developed PD, and there were 272 individuals who developed PD that were not prescribed stimulants. This analysis yielded a HR of 0.419 (HR = 0.419 [95% CI 0.34, 0.516], P = 0.0013).</p><p><strong>Conclusion: </strong>Illicit stimulants are associated with increased risk of PD, but this study suggests prescribed stimulants may not impart that same risk. The reduced risk in this cohort may be due to protection from illicit substance use and oxidative stress, however additional study exploring the relationship between prescription stimulants and PD is warranted.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"605-609"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10466953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"It was a very awkward consultation because I didn't know"-general practice staff experiences and challenges in providing healthcare to gender and sexual minority youth in Aotearoa New Zealand. "这是一次非常尴尬的咨询,因为我不知道"--在新西兰奥特亚罗瓦,全科医生在为性别和性少数群体青年提供医疗保健服务方面的经验和挑战。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmad024
Rona Carroll, Sonya J Morgan, Alex Ker, Susan M Garrett, Sally B Rose, Tracey Gardiner, Eileen M McKinlay

Background: Rainbow young people (RYP; people of diverse genders, sexualities, and variations in sex characteristics) face barriers accessing primary care, often report negative experiences and the need to educate clinicians on rainbow-specific issues. This study explores general practice staff views and experiences of providing care to RYP.

Methods: Three focus groups were held with staff from 5 general practices in an urban area of Aotearoa New Zealand (25 participants in total). Practices were purposively selected to include some known to be more "rainbow-friendly" seeing larger numbers of RYP and some with no particular focus on RYP. All members of each practice were invited to participate, including administration and reception staff. Focus groups were audio-recorded, transcribed, and analysed in NVivo using inductive thematic analysis.

Results: Four main themes were identified: (i) Practice experience, (ii) Feeling awkward, (iii) Knowledge and training, and (iv) Structural barriers. Differences were apparent in health provider knowledge, comfort, and experience in providing care to RYP. Participants identified a lack of knowledge and training and wanted more resources and education. Systems limitations were common (e.g. with IT systems for recording gender) and often contributed to awkward clinical encounters.

Conclusions: Participants recognized shortcomings in their training, knowledge, and level of confidence providing care to RYP and expressed a desire to improve their competency. Further work is needed to identify and trial practical strategies that help improve communication skills, knowledge, and the delivery of more equitable healthcare to RYP.

背景:彩虹青年(RYP;具有不同性别、性取向和性特征差异的人)在获得初级保健服务时面临障碍,经常有负面经历,需要对临床医生进行彩虹特定问题的教育。本研究探讨了全科医生在为 RYP 提供医疗服务时的观点和经验:方法:与来自新西兰奥特亚罗瓦一个城市地区的 5 家全科诊所的员工(共 25 名参与者)举行了三次焦点小组讨论。这些诊所是有目的性地挑选出来的,包括一些众所周知的 "彩虹友好型 "诊所,这些诊所有较多的青少年患者,也包括一些并不特别关注青少年患者的诊所。每个诊所的所有成员都被邀请参加,包括行政人员和接待人员。对焦点小组进行了录音、转录,并使用归纳式主题分析法在 NVivo 中进行了分析:结果:确定了四个主要专题:(i) 实践经验,(ii) 感觉尴尬,(iii) 知识和培训,以及 (iv) 结构性障碍。医疗服务提供者在为青少年提供医疗服务时,在知识、舒适度和经验方面存在明显差异。参与者认为缺乏知识和培训,希望获得更多的资源和教育。系统方面的限制也很常见(如记录性别的信息技术系统),这往往会导致尴尬的临床接触:参与者认识到他们在培训、知识和为 RYP 提供护理的信心水平方面存在不足,并表示希望提高他们的能力。需要进一步开展工作,以确定和试用实用的策略,帮助提高沟通技巧和知识,并为遥感青少年提供更公平的医疗保健服务。
{"title":"\"It was a very awkward consultation because I didn't know\"-general practice staff experiences and challenges in providing healthcare to gender and sexual minority youth in Aotearoa New Zealand.","authors":"Rona Carroll, Sonya J Morgan, Alex Ker, Susan M Garrett, Sally B Rose, Tracey Gardiner, Eileen M McKinlay","doi":"10.1093/fampra/cmad024","DOIUrl":"10.1093/fampra/cmad024","url":null,"abstract":"<p><strong>Background: </strong>Rainbow young people (RYP; people of diverse genders, sexualities, and variations in sex characteristics) face barriers accessing primary care, often report negative experiences and the need to educate clinicians on rainbow-specific issues. This study explores general practice staff views and experiences of providing care to RYP.</p><p><strong>Methods: </strong>Three focus groups were held with staff from 5 general practices in an urban area of Aotearoa New Zealand (25 participants in total). Practices were purposively selected to include some known to be more \"rainbow-friendly\" seeing larger numbers of RYP and some with no particular focus on RYP. All members of each practice were invited to participate, including administration and reception staff. Focus groups were audio-recorded, transcribed, and analysed in NVivo using inductive thematic analysis.</p><p><strong>Results: </strong>Four main themes were identified: (i) Practice experience, (ii) Feeling awkward, (iii) Knowledge and training, and (iv) Structural barriers. Differences were apparent in health provider knowledge, comfort, and experience in providing care to RYP. Participants identified a lack of knowledge and training and wanted more resources and education. Systems limitations were common (e.g. with IT systems for recording gender) and often contributed to awkward clinical encounters.</p><p><strong>Conclusions: </strong>Participants recognized shortcomings in their training, knowledge, and level of confidence providing care to RYP and expressed a desire to improve their competency. Further work is needed to identify and trial practical strategies that help improve communication skills, knowledge, and the delivery of more equitable healthcare to RYP.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"579-586"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11324325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9097481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The quality of paediatric asthma guidelines: evidence underpinning diagnostic test recommendations from a meta-epidemiological study. 儿科哮喘指南的质量:一项元流行病学研究提出的诊断测试建议的依据。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmad052
Elizabeth T Thomas, Sarah T Thomas, Rafael Perera, Peter J Gill, Susan Moloney, Carl J Heneghan

Background: Asthma is one of the most frequent reasons children visit a general practitioner (GP). The diagnosis of childhood asthma is challenging, and a variety of diagnostic tests for asthma exist. GPs may refer to clinical practice guidelines when deciding which tests, if any, are appropriate, but the quality of these guidelines is unknown.

Objectives: To determine (i) the methodological quality and reporting of paediatric guidelines for the diagnosis of childhood asthma in primary care, and (ii) the strength of evidence supporting diagnostic test recommendations.

Design: Meta-epidemiological study of English-language guidelines from the United Kingdom and other high-income countries with comparable primary care systems including diagnostic testing recommendations for childhood asthma in primary care. The AGREE-II tool was used to assess the quality and reporting of the guidelines. The quality of the evidence was assessed using GRADE.

Results: Eleven guidelines met the eligibility criteria. The methodology and reporting quality varied across the AGREE II domains (median score 4.5 out of 7, range 2-6). The quality of evidence supporting diagnostic recommendations was generally of very low quality. All guidelines recommended the use of spirometry and reversibility testing for children aged ≥5 years, however, the recommended spirometry thresholds for diagnosis differed across guidelines. There were disagreements in testing recommendations for 3 of the 7 included tests.

Conclusions: The variable quality of guidelines, lack of good quality evidence, and inconsistent recommendations for diagnostic tests may contribute to poor clinician adherence to guidelines and variation in testing for diagnosing childhood asthma.

背景:哮喘是儿童看全科医生(GP)最常见的原因之一。儿童哮喘的诊断具有挑战性,目前有多种哮喘诊断测试。全科医生在决定进行哪些检查(如果有的话)时可能会参考临床实践指南,但这些指南的质量尚不清楚:目的:确定(i)儿科指南在初级医疗中诊断儿童哮喘的方法质量和报告情况,以及(ii)支持诊断测试建议的证据强度:元流行病学研究:对英国和其他具有类似初级医疗系统的高收入国家的英语指南进行研究,包括初级医疗中儿童哮喘的诊断检测建议。AGREE-II工具用于评估指南的质量和报告。结果:结果:11 份指南符合资格标准。在 AGREE II 的各个领域中,方法和报告质量各不相同(中位数为 4.5 分,满分为 7 分,范围为 2-6 分)。支持诊断建议的证据质量普遍很低。所有指南都建议对年龄≥5 岁的儿童进行肺活量测定和可逆性测试,但各指南推荐的肺活量测定诊断阈值有所不同。在纳入的 7 项检测中,有 3 项的检测建议存在分歧:结论:指南质量参差不齐、缺乏优质证据以及诊断测试建议不一致,可能会导致临床医生对指南的依从性差以及诊断儿童哮喘测试的差异。
{"title":"The quality of paediatric asthma guidelines: evidence underpinning diagnostic test recommendations from a meta-epidemiological study.","authors":"Elizabeth T Thomas, Sarah T Thomas, Rafael Perera, Peter J Gill, Susan Moloney, Carl J Heneghan","doi":"10.1093/fampra/cmad052","DOIUrl":"10.1093/fampra/cmad052","url":null,"abstract":"<p><strong>Background: </strong>Asthma is one of the most frequent reasons children visit a general practitioner (GP). The diagnosis of childhood asthma is challenging, and a variety of diagnostic tests for asthma exist. GPs may refer to clinical practice guidelines when deciding which tests, if any, are appropriate, but the quality of these guidelines is unknown.</p><p><strong>Objectives: </strong>To determine (i) the methodological quality and reporting of paediatric guidelines for the diagnosis of childhood asthma in primary care, and (ii) the strength of evidence supporting diagnostic test recommendations.</p><p><strong>Design: </strong>Meta-epidemiological study of English-language guidelines from the United Kingdom and other high-income countries with comparable primary care systems including diagnostic testing recommendations for childhood asthma in primary care. The AGREE-II tool was used to assess the quality and reporting of the guidelines. The quality of the evidence was assessed using GRADE.</p><p><strong>Results: </strong>Eleven guidelines met the eligibility criteria. The methodology and reporting quality varied across the AGREE II domains (median score 4.5 out of 7, range 2-6). The quality of evidence supporting diagnostic recommendations was generally of very low quality. All guidelines recommended the use of spirometry and reversibility testing for children aged ≥5 years, however, the recommended spirometry thresholds for diagnosis differed across guidelines. There were disagreements in testing recommendations for 3 of the 7 included tests.</p><p><strong>Conclusions: </strong>The variable quality of guidelines, lack of good quality evidence, and inconsistent recommendations for diagnostic tests may contribute to poor clinician adherence to guidelines and variation in testing for diagnosing childhood asthma.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"460-469"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11324322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostics and management of headache in general practice. 全科医生对头痛的诊断和处理。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmac121
Louise Ninett Carlsen, Simon Stefansen, Peder Ahnfeldt-Mollerup, Rigmor Højland Jensen, Espen Saxhaug Kristoffersen, Jakob Møller Hansen, Jesper Lykkegaard

Background: Headache disorders are globally prevalent and insufficient treatment contribute to low quality of life, increased disability, and socioeconomic costs. However, headache can to a large extent be treated appropriately by general practitioners.

Objective: To explore general practitioners' (GPs') management of patients with headache lasting ≥6 months.

Methods: In this retrospective descriptive cross-sectional study based on medical audit, all GPs practicing in Vejle municipality (population 116,992), Denmark, were invited to review their latest 20 patients with headache. Outcome measures were headache diagnostics, treatment, and referrals. Factors associated with referral to neurological treatment were examined by logistic regression.

Results: Of 26 invited practices, 19 participated reporting on 367 patients with lasting headache (71.4% women; mean-age 48.5 years). One hundred and sixty-one patients had migraine (44%; IQR: 28-60%), 140 (38%; IQR: 25-44%) had tension-type headache; 243 (66%; IQR: 50-79%) used simple analgesics, 147 (40%; IQR: 29-59%) triptans, 37 (10%; IQR: 0-14%) opioids, 93 (25%; IQR: 20-35%) were prescribed preventive medication; 176 (48%; IQR: 48-59%) were referred to neurologist, and 92 (25%; IQR: 10-37%) were referred to CT or MRI scan. Associated factors for referral were >1 headache diagnosis (aOR 1.75 [95% CI: 1.05-2.95]; P = 0.03), post-traumatic headache (aOR 2.53 [95% CI: 1.25-5.38]; P = 0.01), unspecific headache (aOR 2.04 [95% CI: 1.08-3.93]; P = 0.03), and using preventive treatment (aOR 2.75 [95% CI: 1.68-4.57]; P < 0.001).

Conclusion: This study provides insights to how GPs manage patients with long-lasting headache. Focus should be on reducing opioids, increasing preventive treatment, and keeping more patients in primary care.

背景:头痛疾病在全球普遍存在,治疗不足导致生活质量低下、残疾增加和社会经济成本增加。然而,全科医生在很大程度上可以对头痛进行适当治疗:目的:探讨全科医生(GPs)对持续时间≥6 个月的头痛患者的管理方法:在这项以医疗审计为基础的回顾性描述性横断面研究中,丹麦Vejle市(人口116,992人)的所有全科医生受邀对最近20名头痛患者进行复查。研究结果包括头痛诊断、治疗和转诊。通过逻辑回归分析了与转诊至神经科治疗相关的因素:在 26 家受邀诊所中,有 19 家参与了调查,报告了 367 名长期头痛患者(71.4% 为女性;平均年龄 48.5 岁)的情况。161名患者患有偏头痛(44%;IQR:28-60%),140名(38%;IQR:25-44%)患有紧张型头痛;243名(66%;IQR:50-79%)患者使用了简单的镇痛药,147名(40%;IQR:29-59%)患者使用了三苯氧胺,37名(10%;IQR:0-14%)患者使用了阿片类药物:176(48%;IQR:48-59%)人被转诊至神经科,92(25%;IQR:10-37%)人被转诊至 CT 或 MRI 扫描科。转诊的相关因素包括:头痛诊断次数大于 1 次(aOR 1.75 [95% CI:1.05-2.95];P = 0.03)、创伤后头痛(aOR 2.53 [95% CI:1.25-5.38];P = 0.01)。38]; P = 0.01)、非特异性头痛(aOR 2.04 [95% CI: 1.08-3.93]; P = 0.03)和使用预防性治疗(aOR 2.75 [95% CI: 1.68-4.57]; P < 0.001):本研究为全科医生如何管理长期头痛患者提供了启示。重点应放在减少阿片类药物、增加预防性治疗以及让更多患者留在全科医疗机构。
{"title":"Diagnostics and management of headache in general practice.","authors":"Louise Ninett Carlsen, Simon Stefansen, Peder Ahnfeldt-Mollerup, Rigmor Højland Jensen, Espen Saxhaug Kristoffersen, Jakob Møller Hansen, Jesper Lykkegaard","doi":"10.1093/fampra/cmac121","DOIUrl":"10.1093/fampra/cmac121","url":null,"abstract":"<p><strong>Background: </strong>Headache disorders are globally prevalent and insufficient treatment contribute to low quality of life, increased disability, and socioeconomic costs. However, headache can to a large extent be treated appropriately by general practitioners.</p><p><strong>Objective: </strong>To explore general practitioners' (GPs') management of patients with headache lasting ≥6 months.</p><p><strong>Methods: </strong>In this retrospective descriptive cross-sectional study based on medical audit, all GPs practicing in Vejle municipality (population 116,992), Denmark, were invited to review their latest 20 patients with headache. Outcome measures were headache diagnostics, treatment, and referrals. Factors associated with referral to neurological treatment were examined by logistic regression.</p><p><strong>Results: </strong>Of 26 invited practices, 19 participated reporting on 367 patients with lasting headache (71.4% women; mean-age 48.5 years). One hundred and sixty-one patients had migraine (44%; IQR: 28-60%), 140 (38%; IQR: 25-44%) had tension-type headache; 243 (66%; IQR: 50-79%) used simple analgesics, 147 (40%; IQR: 29-59%) triptans, 37 (10%; IQR: 0-14%) opioids, 93 (25%; IQR: 20-35%) were prescribed preventive medication; 176 (48%; IQR: 48-59%) were referred to neurologist, and 92 (25%; IQR: 10-37%) were referred to CT or MRI scan. Associated factors for referral were >1 headache diagnosis (aOR 1.75 [95% CI: 1.05-2.95]; P = 0.03), post-traumatic headache (aOR 2.53 [95% CI: 1.25-5.38]; P = 0.01), unspecific headache (aOR 2.04 [95% CI: 1.08-3.93]; P = 0.03), and using preventive treatment (aOR 2.75 [95% CI: 1.68-4.57]; P < 0.001).</p><p><strong>Conclusion: </strong>This study provides insights to how GPs manage patients with long-lasting headache. Focus should be on reducing opioids, increasing preventive treatment, and keeping more patients in primary care.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"470-476"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9170544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults. 与初级保健老年人阿片类药物和可能不适当的阿片类药物处方相关的自我评定身心健康和生活满意度的变化。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-14 DOI: 10.1093/fampra/cmad050
Isabelle Pitrou, Carina D'Aiuto, Carlotta Lunghi, Line Guénette, Djamal Berbiche, Karine Bertrand, Helen-Maria Vasiliadis

Objective: To examine changes in life satisfaction and physical and mental health associated with opioid and potentially inappropriate opioid prescribing (PIOP) among older adults.

Methods: Secondary data analysis from the Étude sur la Santé des Aînés (ESA)-Services study. The sample consisted of 945 older adults recruited in primary care with available health survey information linked to administrative medical record data. The exposure of interest was categorized as no prescription, opioid prescription, and PIOP, defined using the Beers criteria. Outcomes were self-rated physical health, mental health, and life satisfaction measured at baseline and at a 3-year follow-up. Generalized estimating equations were used to examine 3-year changes in outcomes as a function of opioid prescribing. Analyses were adjusted for covariates relating to health, psychosocial, and sociodemographic factors as well as duration/frequency of opioid prescribing. Analyses were conducted in the overall sample and in non-cancer patients.

Results: The sample had an average age of 73.1 years; the majority was Canadian-born (96.3%) while females made up over half (55.4%) the sample. Compared to not receiving an opioid prescription, PIOP was associated with a deterioration in physical health (ORadjusted = 0.65; 95%CI = 0.49, 0.86), but not mental health and life satisfaction. In non-cancer patients, PIOP was associated with poorer physical health (ORadjusted = 0.59; 95%CI = 0.40, 0.87) and opioid prescribing was marginally associated with improved life satisfaction (ORadjusted = 1.58; 95%CI = 0.96, 2.60).

Conclusion: PIOP was associated with a deterioration in physical health. Patient-centred chronic pain management and the effect on health and well-being require further study in older adults.

目的研究老年人中与阿片类药物和潜在阿片类药物不当处方(PIOP)相关的生活满意度和身心健康的变化:方法:对Étude sur la Santé des Aînés (ESA)-Services 研究进行二次数据分析。样本包括 945 名接受初级保健服务的老年人,其健康调查信息与行政医疗记录数据相关联。根据 Beers 标准,相关暴露分为无处方、阿片类处方和 PIOP。研究结果是在基线和 3 年随访时测量的自我评定的身体健康、心理健康和生活满意度。使用广义估计方程来检验阿片类药物处方对结果的 3 年影响。根据与健康、社会心理和社会人口因素有关的协变量以及阿片类药物处方的持续时间/频率对分析结果进行了调整。对总体样本和非癌症患者进行了分析:样本的平均年龄为 73.1 岁,大多数在加拿大出生(96.3%),女性占样本的一半以上(55.4%)。与未收到阿片类药物处方相比,PIOP 与身体健康状况恶化有关(OR 调整后 = 0.65;95%CI = 0.49,0.86),但与心理健康和生活满意度无关。在非癌症患者中,PIOP 与较差的身体健康状况有关(调整后 OR = 0.59;95%CI = 0.40,0.87),而阿片类药物处方与生活满意度的改善略有关联(调整后 OR = 1.58;95%CI = 0.96,2.60):结论:PIOP 与身体健康状况恶化有关。需要在老年人中进一步研究以患者为中心的慢性疼痛管理及其对健康和幸福的影响。
{"title":"Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults.","authors":"Isabelle Pitrou, Carina D'Aiuto, Carlotta Lunghi, Line Guénette, Djamal Berbiche, Karine Bertrand, Helen-Maria Vasiliadis","doi":"10.1093/fampra/cmad050","DOIUrl":"10.1093/fampra/cmad050","url":null,"abstract":"<p><strong>Objective: </strong>To examine changes in life satisfaction and physical and mental health associated with opioid and potentially inappropriate opioid prescribing (PIOP) among older adults.</p><p><strong>Methods: </strong>Secondary data analysis from the Étude sur la Santé des Aînés (ESA)-Services study. The sample consisted of 945 older adults recruited in primary care with available health survey information linked to administrative medical record data. The exposure of interest was categorized as no prescription, opioid prescription, and PIOP, defined using the Beers criteria. Outcomes were self-rated physical health, mental health, and life satisfaction measured at baseline and at a 3-year follow-up. Generalized estimating equations were used to examine 3-year changes in outcomes as a function of opioid prescribing. Analyses were adjusted for covariates relating to health, psychosocial, and sociodemographic factors as well as duration/frequency of opioid prescribing. Analyses were conducted in the overall sample and in non-cancer patients.</p><p><strong>Results: </strong>The sample had an average age of 73.1 years; the majority was Canadian-born (96.3%) while females made up over half (55.4%) the sample. Compared to not receiving an opioid prescription, PIOP was associated with a deterioration in physical health (ORadjusted = 0.65; 95%CI = 0.49, 0.86), but not mental health and life satisfaction. In non-cancer patients, PIOP was associated with poorer physical health (ORadjusted = 0.59; 95%CI = 0.40, 0.87) and opioid prescribing was marginally associated with improved life satisfaction (ORadjusted = 1.58; 95%CI = 0.96, 2.60).</p><p><strong>Conclusion: </strong>PIOP was associated with a deterioration in physical health. Patient-centred chronic pain management and the effect on health and well-being require further study in older adults.</p>","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"442-450"},"PeriodicalIF":2.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9365046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tribute to a founding father-Prof. Joe Herman-how to practice Family Medicine. 向开国元勋乔-赫尔曼教授致敬--如何从事全科医学。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-06-12 DOI: 10.1093/fampra/cmad073
Aya Biderman, Yosef Avni, Sody Naimer, Yosef Polachek, Hava Tabenkin, Pesach Shvartzman
{"title":"Tribute to a founding father-Prof. Joe Herman-how to practice Family Medicine.","authors":"Aya Biderman, Yosef Avni, Sody Naimer, Yosef Polachek, Hava Tabenkin, Pesach Shvartzman","doi":"10.1093/fampra/cmad073","DOIUrl":"10.1093/fampra/cmad073","url":null,"abstract":"","PeriodicalId":12209,"journal":{"name":"Family practice","volume":" ","pages":"386-387"},"PeriodicalIF":2.4,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9834918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Family practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1